(Press-News.org) ANN ARBOR—Researchers at the University of Michigan have determined how the hormone leptin, an important regulator of metabolism and body weight, interacts with a key receptor in the brain.
Leptin is a hormone secreted by fat tissue that has been of interest for researchers in obesity and Type 2 diabetes since it was discovered in 1995. Like insulin, leptin is part of a regulatory network that controls intake and expenditure of energy in the body, and a lack of leptin or resistance to it has been linked to obesity in people.
Although there can be several complex reasons behind leptin resistance, in some cases the underlying cause is malfunction of the leptin receptor in the brain. An understanding of how leptin and its receptor interact could lead to new treatments for obesity and metabolic disorders, but the structure of this signaling complex has evaded researchers for years.
Georgios Skiniotis, a faculty member at the Life Sciences Institute and assistant professor in biological chemistry at the U-M Medical School, employed electron microscopy to obtain the first picture of the interaction between leptin and its receptor.
Skiniotis also traced similarities between the leptin receptor and other receptors of the same family, which may provide insight into new targets for treatment of other hormone-related diseases.
"It is exciting not only because it might help with developing new drugs," Skiniotis said. "We now better understand the design and mechanisms of signaling through this class of receptors, which brings us to a whole new set of intriguing questions."
In the paper "Ligand-Induced Architecture of the Leptin Receptor Signaling Complex," published electronically ahead of print on Oct. 11 in Molecular Cell, Skiniotis and his co-authors explain how the receptor is formed by two hinged legs that can swivel until they encounter leptin, which binds to the legs and makes them rigid.
Once the two legs of a receptor become rigid by binding to leptin, they signal to an enzyme called the Janus kinase. A number of drugs have been studied for treatments related to the Janus kinases; inhibiting it may lead to improvement of conditions like rheumatoid arthritis, psoriasis and metabolic disorders that are linked to inflammation.
Alan Saltiel, director of the Life Sciences Institute and a widely cited researcher who works on diabetes, obesity and metabolic disorders, sees a range of possibilities in the work of Skiniotis.
"This study may help solve an important issue we've been struggling with for some time," he said. "Since leptin is a master regulator of appetite, understanding why resistance to its effects develops in obesity has been a major obstacle to discovering new drugs for obesity and diabetes. Developing a clear picture of how leptin can bind to its receptor may be the first step in overcoming leptin resistance."
###Other U-M authors on the paper were Liliya Mancour and Gerwin Westfield of the Life Sciences Institute and Department of Biological Chemistry and Hikmat Daghestani, Somnath Dutta, Justin Schilling, Austin Oleskie, Jeffrey Herbstman and Steven Chou of the Life Sciences Institute.
The work in Skiniotis' lab was supported by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of General Medical Sciences Pharmacological Sciences Training Program. Skiniotis is a Pew Scholar of Biomedical Sciences.
Target for obesity drugs comes into focus
2012-10-11
ELSE PRESS RELEASES FROM THIS DATE:
Large international study finds 21 genes tied to cholesterol levels
2012-10-11
In the largest-ever genetic study of cholesterol and other blood lipids, an international consortium has identified 21 new gene variants associated with risks of heart disease and metabolic disorders. The findings expand the list of potential targets for drugs and other treatments for lipid-related cardiovascular disease, a leading global cause of death and disability.
The International IBC Lipid Genetics Consortium used the Cardiochip, a gene analysis tool invented by Brendan J. Keating, Ph.D., a scientist at the Center for Applied Genomics at The Children's Hospital ...
Feeding the Schwanns: New technique could bring cell therapy for nerve damage a step closer
2012-10-11
A new way to grow cells vital for nerve repair, developed by researchers from the University of Sheffield, could be a vital step for use in patients with severe nerve damage, including spinal injury (1).
Schwann cells are known to boost and amplify nerve growth in animal models, but their clinical use has been held back because they are difficult, time-consuming and costly to culture.
The Sheffield team, led by Professor John Haycock, has developed a new technique with adult rat tissue which overcomes all these problems, producing Schwann cells in less than half the time ...
New tool determines leukemia cells' 'readiness to die,' may guide clinical care
2012-10-11
Researchers at Dana-Farber Cancer Institute have developed a novel method for determining how ready acute myeloid leukemia (AML) cells are to die, a discovery that may help cancer specialists to choose treatments option more effectively for their patients who have AML.
In a study published in the Oct. 12 issue of the journal Cell, the researchers report that their findings may lead to improved tests to predict which patients successfully treated for AML can continue in remission with standard chemotherapy alone, and which patients are likely to relapse despite ...
Nearby super-Earth likely a diamond planet
2012-10-11
New Haven, Conn. — New research led by Yale University scientists suggests that a rocky planet twice Earth's size orbiting a nearby star is a diamond planet.
"This is our first glimpse of a rocky world with a fundamentally different chemistry from Earth," said lead researcher Nikku Madhusudhan, a Yale postdoctoral researcher in physics and astronomy. "The surface of this planet is likely covered in graphite and diamond rather than water and granite."
The paper reporting the findings has been accepted for publication in the journal Astrophysical Journal Letters.
The ...
A new cave-dwelling reef coral discovered in the Indo-Pacific
2012-10-11
Coral specialist Dr. Bert W. Hoeksema of Naturalis Biodiversity Center in Leiden, The Netherlands, recently published the description of a new coral species that lives on the ceilings of caves in Indo-Pacific coral reefs. It differs from its closest relatives by its small polyp size and by the absence of symbiotic algae, so-called zooxanthellae. Its distribution range overlaps with the Coral Triangle, an area that is famous for its high marine species richness. Marine zoologists of Naturalis visit this area frequently to explore its marine biodiversity.
Reef corals in ...
How food marketers can help consumers eat better while improving their bottom line
2012-10-11
Food marketers are masters at getting people to crave and consume the foods that they promote. In this study authors Dr. Brian Wansink, co-director of the Cornell University Center for Behavioral Economics in Child Nutrition and Professor of Marketing and Dr. Pierre Chandon, professor of Marketing at the leading French graduate school of business, INSEAD challenge popular assumptions that link food marketing and obesity. Their findings presented last weekend at the Association for Consumer Research Conference in Vancouver, Canada point to ways in which smart food marketers ...
Research gives new insight into celiac disease
2012-10-11
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
Published today in Immunity, the discovery was led by Dr Hugh Reid and Professor Jamie Rossjohn of Monash University, Professor Frits Koning of the University of Leiden and Dr Bob Anderson of biotechnology company ImmusanT Inc, based in the US.
An increasingly diagnosed chronic inflammatory disorder, coeliac disease affects the digestive process of the small ...
All healthcare professionals need training to deal with the sexual needs of patients
2012-10-11
Providing healthcare staff with a one-day training course on dealing with the sexual needs of people with an acquired physical disability gave them greater understanding of the issues patients faced and enabled them to address intimate questions more comfortably and proactively.
The findings were so encouraging that the authors of the study, published in the November issue of the Journal of Advanced Nursing, are calling for all healthcare practitioners to receive sexuality training, regardless of their role or the area of healthcare they work in.
Researchers surveyed ...
Queen's develops new environmentally friendly MOF production method
2012-10-11
Chemists at Queen's University Belfast have devised a novel, environmentally friendly technique, which allows the rapid production of Metal-Organic Frameworks porous materials (MOFs).
These revolutionary nanomaterials have the potential to transform hazardous gas storage, natural gas vehicles and drug delivery and have the highest surface-area of any known substance.
A sugar-lump sized piece of MOF material can have the same surface area as a football pitch.
Until now MOF manufacturing techniques have been limited as they are costly, slow and require large quantities ...
Research findings in solar cells will have an impact on solar panel industry
2012-10-11
University of Luxembourg's Laboratory for Photovoltaics has established a method to observe and prevent solar cell degradation before solar cell production is finished, which has implications for the solar cell manufacturing industry since chemical damage to solar cells can occur quickly.
Solar panels are capable of converting light energy from the sun into electrical energy because they contain solar cells – the "power generators" responsible for the energy in solar panels. Thin film solar cells have a coating that is responsible for absorbing the sun's energy, but ...